Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shruthi Melinamani"'
Publikováno v:
Journal of Clinical Oncology. 35:573-573
573 Background: Mutations in Kirstin RAS (KRAS) oncogene play a significant role in the constitutive activation of RAS/RAF/MEK/ERK pathway in CRC. Our objective was to evaluate the association of KRAS mutation status with the clinicopathological char
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6804469c2e5ecdb035d6d3f8eda59d63
https://doi.org/10.1200/jco.2017.35.4_suppl.573
https://doi.org/10.1200/jco.2017.35.4_suppl.573
Autor:
Timothy S. Fenske, Aliyah R. Sohani, Haowei Linda Sun, Michael Jaglal, Scott E. Smith, Adam M. Petrich, Caitlin Handler, Shruthi Melinamani, Andrew D. Zelenetz, Ryan D. Cassaday, Khushboo A Shah, Jeremy D. Whyman, Andrew M. Evens, David Peace, Jeremy S. Abramson, Oliver W. Press, L. Jeffrey Medeiros, Kevin W. Song, Francisco J. Hernandez-Ilizaliturri, Saurabh Rajguru, Nishitha Reddy, Christopher R. Flowers, David T. Yang, Anthony R. Mato, Shaoying Li, Kristie A. Blum, Stefan K. Barta, Julio C. Chavez, Borko Jovanovic, Lisa X Lee, Chadi Nabhan, Julie M. Vose, Daniel J. Landsburg, Jonathon B. Cohen, Reem Karmali, Camille Adeimy, Judy P. Tsai, Jorge J. Castillo, Christina Howlett, Frederick Lansigan, Mitul Gandhi, Namrata Shah, Neil Dalal, Jesse Jaso
Publikováno v:
Blood. 124(15)
Patients with double-hit lymphoma (DHL), which is characterized by rearrangements of MYC and either BCL2 or BCL6, face poor prognoses. We conducted a retrospective multicenter study of the impact of baseline clinical factors, induction therapy, and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d0181577697f792d946aec3112ab64a
https://pubmed.ncbi.nlm.nih.gov/25161267
https://pubmed.ncbi.nlm.nih.gov/25161267
Autor:
John Maciejewski, Stephanie A. Gregory, Shruthi Melinamani, Lela Buckingham, Parameswaran Venugopal, Muhammed Alikhan, Sunita Nathan, Elizabeth Rich, Henry C. Fung, Reem Karmali
Publikováno v:
Biology of Blood and Marrow Transplantation. 19(2)
evaluated the impact of different GM cut-off levels in serum and BAL on mortality. Kaplan Meier curves were used to estimate survival, and Cox proportional hazardsmodels were used to evaluate univariate and adjusted hazards ratios for 180 day all-cau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::855fccd0efef93694c229b6e6276d96d
Autor:
Jeffrey A. Borgia, Zahraa Ibrahem, John C. Kubasiak, Ravi Pithadia, Sanjib Basu, Wen-Rong Lie, Cristina Fhied, Mary J. Fidler, Shruthi Melinamani, Ibdihaj Fughhi, Marta Batus, Philip Bonomi
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 90:S75
11037 Background: Trials evaluating role of bevacizumab in patients with advanced NSCLC have shown only modest impact in outcomes. The objective of this study was to evaluate predictive value of pa...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47791fbcbe750c56fc23bdcb501d598f
https://doi.org/10.1016/j.ijrobp.2014.08.314
https://doi.org/10.1016/j.ijrobp.2014.08.314
Autor:
Jeffrey A. Borgia, Mary J. Fidler, Marta Batus, Philip Bonomi, Shruthi Melinamani, Mohammed S. Azeem, Ravi Pithadia, Sanjib Basu
Publikováno v:
Journal of Clinical Oncology. 32:e19033-e19033
e19033 Background: Weight gain on therapy has a favorable prognosis in non-small cell lung cancer though elevated BMI correltates with inferior outcomes in malignancies such as breast, colon, and e...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1062deccb50f54ec954d8088865a23be
https://doi.org/10.1200/jco.2014.32.15_suppl.e19033
https://doi.org/10.1200/jco.2014.32.15_suppl.e19033
Autor:
Namrata Shah, Aliyah R. Sohani, Jorge J. Castillo, Shruthi Melinamani, Francisco J. Hernandez-Ilizaliturri, Scott E. Smith, Neil Dalal, David Peace, Jeremy S. Abramson, Chadi Nabhan, Julie M. Vose, Mitul Gandhi, Camille Adeimy, Timothy S. Fenske, Andrew M. Evens, Andrew D. Zelenetz, Adam M. Petrich, Borko Jovanvoic, Oliver W. Press, Frederick Lansigan, Khushboo A Shah, Reem Karmali, Stefan K. Barta, Ryan D. Cassaday, Jeremy D. Whyman, Lisa X Lee
Publikováno v:
Blood. 122:640-640
Background DHL are high-grade B-cell lymphomas (BCL) characterized by dual gene rearrangements (RA) of MYC and either BCL2 or BCL6. Outcomes are typically dismal, particularly when treated with R-CHOP, as compared to those observed in patients (pts)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd6932dc78770945d98a48f9973dab4e
https://doi.org/10.1182/blood.v122.21.640.640
https://doi.org/10.1182/blood.v122.21.640.640